# Quorum X Diagnostics, Inc. Simple, faster better diagnostic tests for Covid, Covid-flu, Pneumonia, BV/Yeast, and more. ## Elevator pitch We are developing a line of simple fast diagnostic tools. These include Covid (FDA EUA resubmission May 2022), Flu-Covid, Pneumonia (Prototype ready), BV/Yeast, UTI, etc. - Canonical URL: https://wefunder.com/quorum.x.diagnostics - Entity ID: wefunder:company:57959 - Last updated: 2026-06-22T05:03:07Z - Generated at: 2026-06-22T16:53:16Z ## Quick facts - Preparing for FDA EUA Re-submission in May 2022 with our 4-min Covid test. - đź’Ą Estimated $195 Billion dollar market size for diagnostics by 2027. - 🔬Pipeline includes Fast Tests for Covid, Covid-Flu, Pneumonia, BV/Yeast, & more. - Fast-test for Pseudomnal pneumonia prototype ready projected date 2024. - đź’° 5 International Patent applications and 3 US applications. - đź“Ś Team-5 Science MD/PhDs, plus 100+ years of Business experience & an Army of Interns. ## Active fundraises - wefunder:fundraise:43999: 4(a)(6) successful (USD) - wefunder:fundraise:44000: 4(a)(6) successful (USD) - wefunder:fundraise:29788: 4(a)(6) successful (USD) ## Story Quorum X Diagnostics (QXD) is a women-owned & minority-owned, biotech startup based out of Atlanta, Georgia.We are a medical diagnostic company developing fast, better, simpler diagnostics for at-Home and Point-of-Care. Our first 2 products are the first 4-min Covid Antigen Test called COVIDNOW- the fastest test on the market (presently preparing FDA re-submission) and the FAST-TEST for Pseudomonal Pneumonia (Prototype Ready).Is there still a Covid need and a global Opportunity? COVIDNOW– a 4-minute Covid antigen test, Phone app, and AI reader technology.-Resubmitting for FDA EUA approval this month. -2-10M monthly production capacity-3 go-to-market strategies-1) Shopify website-ready to launch2) We can be nationwide in 1000+Pharmacies w/i weeks of FDA EUA approval via our Physician 360 relationship.3) 4 sales people-ready to goCompetition-Presently, there are 14 at-home kits for Covid-19 however, this is a vast national and global need that will not go away. Pandemic or Endemic people are always going to want to know if they have Covid. However, our test is 2-3X faster than the competition.We are cracking into an industry projected to grow to a $195 Billion dollar industry by 2027.QXD has an amazing team and we're the team to get it DONE!QXD Pipeline Includes: 1) COVIDNOW– a 4-minute Covid antigen test, Phone app, and AI technology.-Resubmitting for FDA EUA approval this month. -2-10M marketing capacity-3 go-to-market strategies-We can be nationwide in 1000+Pharmacies w/i weeks of FDA EUA approval via our Physician 360 relationship2) the FAST-TEST for Pseudomonal pneumonia – #1 and # 2 cause of ventilator and hospital-acquired antibiotic-resistant pneumonia that can result in death. Prototype ready3) BV/YEAST – BV & Candidiasis similar symptoms but with vastly different outcomes. BV increases risk/spread of HIV and impairs childbearing capability. Design In-process4) Exploring- Flu/Covid, Pneumonia Multiplex, Bronchitis, UTI, etc.For the Fast-Test for Pseudomonal pneumonia, the current technology consists of PCR(6-1.5hr-$150) and Culture tests(3+ days $85-200) both techniques are expensive, time-consuming, and require expensive equipment and a highly trained staff. Our test is a 3-min lateral flow that can be completed anywhere simple, fast, and inexpensive.QXD had filed seven total patents, with 5 being international for intellectual property protection, 1 Trademark applicationHOW ARE WE DOING THIS?We listen to bacterial armies as they plan to attack the body (they talk), we identify what they are saying and planning. This allows a faster way of identifying them, quantifying and determining their next move.We are identifying microbes through unique proprietary biomarkers which can reduce testing times from weeks to days on bacteria and 3x faster with Viruses, like COVID.Milestones-Sept 2017-IncorporationSpring, Summer 2018-Preseed raised 100K2018-R&D prototype complete for FAST-TEST for Pseudomonal PneumoniaSummer 2019-PCT utility Patent filedFall 2019-FDA presubmission filedJan 2020-Covid hitsFeb 2020-We decide to do a temporary pivot and start developing a COVID at-home kitMarch 2020-Development beginsSummer 2020- seed raise of $650KSeptember 2020- Prototype ready, Phone app in Process, Patent filed, FDA presubmission complete, Clinical's start,Jan 2021-Clinical's CompleteFeb 2021- FDA EUA application submittedApril 2021- FDA EUA Application Returned with some edits, May 2021-Clinical trial's opened up to test kidsAug 2021- Kid testing completeJan 2022-170K raisedApril 2022-Bench retesting to be completed, FDA EUA re-submissionQXD Deck Version 1159pm SunD5 (1).pdfHIGHLIGHTS:The 4-minute COVIDNOW® antigen test currently has the fastest development time compared to competitive products that currently have EUA approval.COVIDNOW® is SIMPLE. It was designed to be easy to make self-testing at-home a viable option for everyone!QXD’s COVIDNOW® test is an antigen test vs. an antibody test meaning it can detect active infection.The sensitivity of the COVIDNOW® test is able to detect an active infection in asymptomatic individuals.COVIDNOW® does not require a prescription.QXD's partnership with Physician 360, the telemedicine service, provides an additional distribution channel through P360 kiosks located in 1,000+ stores across all 50 states.All patent applications required for the proprietary technology used to produce QXD’s rapid diagnostic tests have been submitted and are currently pending.QXD has a clear exit strategy. Within five years continue the development of the proprietary technology and build out the scientific and organizational infrastructure of the business model at which point it would be optimal for a larger corporation to take the vision to the next level. COVIDNOW® is pending EUA approvalMaking an investment is a huge decision and one that we don’t take lightly. Rest assured, we are dedicated, determined, and passionate about what we are doing.QXD has an amazing team and we're the team to get it DONE! ## FAQ 1. **What makes Quorum X Diagnostics test different from the variations of PCR out there? I am not clear of PCR versus Your test? Is your method proprietary or patented?** - Hi Chester, Great question.   The PCR test is a test that takes the RNA from the virus makes millions of copies and then reads it.  It requires expensive machinery, a laboratory and a highly trained staff and it can take several days to get results.   Our test is a simple at home test,  similar to a pregnancy test, that you can do in the confort of your home and get results in 15 minutes.   Yes, this will  be patented.  2. **Hi Maria, Thank You for your response to my previous questions. With your method, how far along are you in the patent process (i.e. patented pending,??). And as far as you are aware, is your method of testing "Proprietary"? Lastly, On your WeFunder page, what does "Public Laun...** - Hi Chester,Yes, our technology is proprietary knowledge, held under trade-secret. We are in the process of filing the patent now.  Public Launch means that it will be shared on the Wefunder channels on May 29th officially.  It allows friends and family first dibs to invest, but the link is live already. So,  feel free to invest.  We would greatly appreciate it!Thank you,Maria  3. **How are you getting human samples to test? Do you have a medical director, CLIA licence or any other way to validate your results and have a medical system trust your testing? G. Gurda MD, PhD** - Hi Dr. Gurda,  We are still in the process of locating human samples as it appears that we need an IRB before we can acquire samples.  To date, our testing has been with spiked samples and cross-reactivity studies.  We are a small team so we do not have a medical director.  Since we are a research lab we don't need a CLIA certification.  We are ramping up PCR to do some inhouse.  But during clinical's, we will have independent CRA's complete testing to verif... 4. **Hi Maria, Thank you for answering my previous questions. I have a few more. I'm very interested in Quorum X Diagnostics but as all start ups have big risks, I'd just like to inquire a bit more. I noticed you answered two questions on this forum and answered that you're plannin...** -  Hi Chester,Yes, our timeline is still end of summer.  As we are running several activities simultaneously. Luckily, all the government agencies are on our side with accelerated timelines.  For example,  FDA typically takes 3+ months, presently they are approving Emergency use authorization (EUA) in 1-2 weeks.  IRB (Which is the approval for human testing) takes about 1-2 weeks. We are writing IRB this week.  Part of the reason we can move so fast is th... 5. **Hi Maria, A quick follow up: How far along Is Quorum X Diagnostics in their goal pertaining to "First $30K will invest in a SAFE with a $2.75M valuation cap and 25% discount"? The section to "Invest" doesn't reveal where Quorum X Diagnostics stands. Remember ... Knowledge Is P...** - Hi Chester,We have several verbal promises, but presently only have 3K out of 30K actually committed. Thanks! ## Team - Dr. Maria Nagy (CEO) - Dr. Angel A. Rivera (CTO) - Dr. Rodney Nash (Advisor) - Mr. Azad Rahman (Advisor) - Eric Woods (Advisor/Investor) - Dr. Navi Jhita (Advisor) - Sherri Williams (Fundraising & Marketing) - Victoria Chumney Powell (QXD- National Sales Director) ## Recent posts - Time for a birthday wish! (2021-06-08T22:47:36Z) - Correction: WSJ, 'Covid-19 TESTING...' (2021-06-07T03:31:47Z) - Wall Street Journal, 'COVID-19 Could Be Viable Business Bet' (2021-06-07T02:37:32Z) - Get In Line for COVIDNOW (2021-06-01T01:00:30Z) - We are QXD - Meet all the team members... (2021-05-27T23:06:54Z) - News: Breakthrough COVID cases emerge. (2021-05-14T19:17:31Z) - QXD Investors Star in COVIDNOW Intro Video (2021-05-06T01:59:14Z) - Courtesy of Georgia Bio, the word on COVIDNOW & QXD is out there! (2021-04-19T19:34:15Z) - FOR IMMEDIATE RELEASE: Help Us Break the COVIDNOW Story! (2021-04-17T18:30:43Z) - COVIDNOW® Waitlist GROWS! (2021-03-30T21:18:23Z) - COVIDNOW® Passes Phase I Review (2021-02-18T02:14:32Z) - Shout-out from one biotech start-up to another (2021-02-02T13:29:14Z) - QXD's FDA Submission is Official! (2021-01-20T18:07:14Z) - CovidNow & the Emerging SARS-CoV-2 Variants (2021-01-04T13:11:16Z) - All hands on deck... (2020-12-26T23:42:24Z) ## Q&A - Q: With the Trump administration looking for a rapid result test and 400 million US dollars set aside for test development it would be the perfect time to reach all your government affiliates and get a few sticks into the White House, CDC, FDA, etc. For evaluation. Hopefully that would lead to an order in the millions of dollars... Now is the time to strike while the iron is hot. - A: Hey Chris,Do you have any contacts?   - Q: How does the availability of vacines impact your business? Is there more opportunity on the international side? How are you addressing it? - A: Hi Noel and thanks for the great questions! We strongly believe COVIDNOW has a viable place in the market even with the vaccine rollout. The QXD team is steadily working behind the scenes to stay on top of marketing trends. The team has been tweaking and refining as we wait for an official word from the FDA regarding COVIDNOW's EUA approval. As far as opportunity on the international front, yes there is opportunity abroad. Since COVIDNOW addresses a global need, the international piece has been included in our development plans from the very beginning. Thanks again for the questions and hope this helps. - Q: What's new with the QXD business? - A: Hi Keith! Thanks for your question. Actually, I posted an update just yesterday. If you click on the 'UPDATES' page, you'll be able to see all updates and past posts. Right now, COVIDNOW is pending EUA approval from the U.S. FDA. The post yesterday was just a quick update that things are rolling along behind the scenes AND that the QXD team has been working closely with the FDA since submitting the EUA application. While we wait, the team is preparing and getting ready so when/if we receive the green light, we'll be all systems go! - Q: Is there any Covid-19 virus variant for which this test will not work? - A: Great question. I do know that COVIDNOW has been shown to detect the American, UK, and South African Variants of Sars-CoV-2. Thanks for the question! - Q: Thank you all for your hard work and keep plowing forward head first through the test competition. - A: Thanks Chris. I know the team appreciates the encouragement. They are a very determined and dedicated group and are very excited that the end of clinicals is in sight. - Q: is the company still alive? - A: Yes!!! We are still alive. I will make a formal update soon. Thanks! We are just so busy. - Q: Any news on the process of getting the product approved for the market? - A: Hi Mads, Nice to hear from you. We have been working with UGA since the middle of March. We are finishing up that last bit of testing we are working on experiments 4 of 4. We are also in deep due diligence with an investment banking group in an effort to raise VC funding. I will make a big update as soon as the testing is complete. - Q: Hi, Are there any updates to share? - A: Nice to hear from you. We have been working with UGA since the middle of March. We are finishing up that last bit of testing we are working on experiments 4 of 4. We are also in deep due diligence with an investment banking group in an effort to raise VC funding. I will make a big update as soon as the testing is complete. - Q: I had purchased contracts back in August 2020 and was not notified of any funding rounds and it appears a new funding round will be occurring - can these contracts be executed during this round because it was supposed to be done on preferred stock - A: Hi Paul! You are correct, we just announced the 2nd funding round (starting May 3). The S.A.F.E. from the previous round is still intact so there is no conversion at this time. Thanks so much for your support. - Q: Do you have the capability to supply if there are orders from other countries? - A: Hi Omar! Thanks so much for your question. The monies raised through the Wefunder campaign provided the resources to fulfill the Physician 360 pre-order which was doubled from its original amount! It is my understanding that QXD will still have a supply of units beyond that order to fulfill other orders but I do not have that exact number. And, of course, it's all pending EUA approval. - Q: Hi Maria, Any plan to extend your fund raising beyond 4th Dec? - A: Hi Yip Wai,  no that is the last day they will let us raise.   We may need to close a week or so earlier too due to the holidays.  - A: Hi Yip, As you might have seen. We are closing Dec. 4th. See you there! :) - Q: Is the COVI-TRACE (Diagnostic Test for the Detection of SARS-CoV-2 Virus in Saliva) kit by Sorrento Therapeutics a competitor? If yes, could you compare your progress with theirs? - A: Hi Omar,Thanks for asking.  This saliva test.  Is an at-home collection kit.  You spit in a tube and mail it away to a lab.  Then they perform the PCR test.  The results can still take several days. Our test you get the whole kit at one time. Perform the test yourself and have the result in 15 min. - Q: Hi Maria, I think this is a fanstastic idea. I am excited not only for your COVID testing but also for your plans to create more tests in the future. Your bv, candida and UTI tests would be extremely helpful for millions of women. Have you considered an EBV test? Will investing now contribute to the company as a whole and therefore future innovations? I am a bit confused with what the investors receive in return. Thanks and be well - A: Hi Gabrielle, Thank you for your kind words.  Screening for viruses, like EBV, is a little bit tricker than bacteria but it is something to consider in the future. Yes, investing now you are investing in the whole company and all future technologies.  As an investor, you are actually purchasing stock in the company.  The returns will happen several years down the line when there is either an acquisition or an IPO.  So not only do you get stock in the company based on a 3M dollar valuation but in the short term there are small perks that you will receive these include a handwritten thank you card and then some COVID NOW sticks upon EUA approval. For investments of 10K or more will get a tour of the lab and lunch with the team.  There are more details on the perks section of our campaign. - Q: Do you intend to pay a dividend (post-SAFE conversion)? - A: Hi Craig!  Thanks for the question.  We are not planning on dividends at this time. Thanks! Maria - Q: I would like to know about the company’s current status and what is the exit plan for a small investor like me. - A: We are still fundraising with our investment bankers. On the science side, we are working on a prototype for bacterial and fungal vaginitis. All investors big and small exist at the same time, when we get aquired.